India launches nutraceutical trade expo ‘Bharat Nutraverse’
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
Surpassing 1,000 Company Owned Company Operated stores
Subscribe To Our Newsletter & Stay Updated